Potential Survival Benefit of Polymyxin B Hemoperfusion in Septic Shock Patients on Continuous Renal Replacement Therapy: A Propensity-Matched Analysis

Publisher： Karger

E-ISSN： 1421-9735|42|1|9-17

ISSN： 0253-5068

Source： Blood Purification, Vol.42, Iss.1, 2016-02, pp. : 9-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Time to Initiation of Treatment with Polymyxin B Cartridge Hemoperfusion in Septic Shock Patients

By  

Blood Purification, Vol. 33, Iss. 4, 2012-03 ,pp. : 252-256

Karger

Access to resources Recommend Favorite

Changes in Plasma Interleukin-18 by Direct Hemoperfusion with Polymyxin B-Immobilized Fiber in Patients with Septic Shock

By  

Blood Purification, Vol. 23, Iss. 6, 2005-12 ,pp. : 417-420

Karger

Access to resources Recommend Favorite

Hemoperfusion with Polymyxin B- Immobilized Fiber Attenuates the Increased Plasma Levels of Thrombomodulin and von Willebrand Factor from Patients with Septic Shock

By  

Blood Purification, Vol. 16, Iss. 4, 1998-09 ,pp. : 179-186

Karger

Access to resources Recommend Favorite

Spironolactone Treatment and Effect on Survival in Chronic Heart Failure Patients with Reduced Renal Function: A Propensity-Matched Study

By  

Cardiorenal Medicine, Vol. 7, Iss. 2, 2017-01 ,pp. : 128-136

Karger

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Polymyxin-B Immobilized Fiber Column and Conventional Medical Therapy in the Management of Abdominal Septic Shock in Italy

By  

Blood Purification, Vol. 32, Iss. 4, 2011-11 ,pp. : 331-340

Karger

Access to resources Recommend Favorite